The Claim

The claim tested on this page is object identity: the characteristic soft green or tan lumps seen in stool shortly after traditional olive-oil-and-citrus gallbladder or liver flushes are alleged to be pre-existing gallstones physically expelled from the gallbladder.

This is testable by chemically analyzing the recovered material, comparing its structure with confirmed biliary stones, and determining whether the same material can form from the ingredients in the intestinal environment. Color, softness, buoyancy and temporal proximity to taking oil do not independently identify the source of an object.

Two neighboring claims have different endpoints and are not decided here: whether some diet/medicine/flush changes stones visible on ultrasound, and whether the lumps contain specified toxins whose total burden has decreased. The former requires controlled serial imaging (repeat scans taken at different times); the latter requires chemical identification and clearance measures.

Where It Comes From

Oil-based liver and gallbladder flushes have circulated for decades in alternative-health books, clinics and online communities. Their strongest visual evidence is immediate: people may pass many soft globules after the procedure and interpret them as stones that had been hidden in the biliary system.

More recently, case reports with ultrasound imaging have been cited as stronger evidence that some regimens might change true gallstones. Those reports deserve separate evaluation rather than being used retroactively to identify every stool lump as a gallstone.

Why It Sounds Convincing

The procedure produces something a person can see. A physical object feels more persuasive than an abstract biomarker. If the lumps appear only after the cleanse, it is natural to infer that the cleanse expelled them from the body.

Gallstones are also familiar as solid objects, so the visual analogy is powerful. But appearance alone cannot determine origin or chemical composition.

The Short Answer

The soft green lumps passed after a typical oil-and-citrus “liver flush” are not reliable evidence that gallstones have been removed. Researchers examined material passed after such a flush and found that it did not have the usual properties of gallstones; similar lumps could form from the ingredients themselves.

That finding concerns the identity of the visible lumps. It does not mean that every lump passed by every person has been tested. To find out whether a real gallstone has changed or disappeared, investigators need medical imaging, not the appearance of stool.

Studies of prescription medicines or experimental dietary-fat formulations ask different treatment questions. Their results should not be presented as proof that the familiar home cleanse removes stones or unspecified “toxins.”

How It Would Have to Work

A flush claimed to expel existing gallstones should cause documented stones to leave the gallbladder and pass through the biliary ducts into the intestine without causing obstruction. The material recovered in stool should match gallstone composition and morphology.

A claim of dissolving or shrinking gallstones over time requires a different test: reliable pre/post imaging, a defined intervention, appropriate follow-up and ideally controls capable of separating treatment effects from measurement variation or natural change.

What Actually Happens

Large quantities of oil and other ingredients undergo digestion and chemical transformation in the intestine. Under some conditions they can form soft, soap-like globules. Their color and shape can resemble what people expect a “stone” to look like.

True gallstones vary in composition, often involving cholesterol, pigments and calcium salts. They form in the gallbladder and are not identified by visual inspection of stool alone.

What the Evidence Shows

What are the green lumps?

The clearest test examined the objects people point to as proof of a successful flush. In a 2005 chemical investigation published in The Lancet, the recovered soft material did not behave like an ordinary gallstone, and similar lumps could be produced using ingredients from the cleanse. That provides a straightforward alternative explanation: a dramatic-looking object can form during the flush rather than having been stored in the gallbladder.

This was a case-based investigation, not chemical testing of every possible specimen. Its strength is that it examined the claimed evidence directly rather than relying on photographs.

How would we test removal of real gallstones?

A genuine gallstone can be documented with ultrasound before and after treatment. A handful of case reports describe changing ultrasound findings while people followed multiple regimens. They cannot show which ingredient, natural change or other treatment was responsible—and they do not establish that the green stool lumps were the imaged stones.

Researchers have also tested other approaches. A small randomized study compared prescription gallstone medication alone with the same medication plus omega-3 fatty acids. The combination produced more signs of change on imaging, but evidence for complete disappearance of stones was much less convincing. The trial was small, had some inconsistent statistical reporting and did not test the classic liver flush.

Another research group has published a plan to test a specific fatty-acid preparation against a comparison treatment in people with very small gallstones. The study design and registry have unresolved differences about which follow-up result counts as the main outcome. A protocol is a plan, not proof that the treatment works; the registered study had no posted results at the last review. Its preparation and treatment schedule also differ from the popular oil-and-lemon cleanse.

What does this establish?

None of these adjacent treatment studies shows that the familiar soft green objects are expelled gallstones. And calling those objects “liver toxins” does not identify any toxin: that would require separate chemical evidence.

The Strongest Evidence for the Claim

The best evidence for genuine gallstone removal would be a stone visible on an initial scan and demonstrably absent or smaller on a later scan, with a credible comparison ruling out other explanations.

Some case reports and trials involving different treatments do report changes on imaging. They are worth studying for those specific treatments. They do not show that a home liver flush causes the change, or that its characteristic green stool lumps are the same objects seen inside the gallbladder.

The Strongest Evidence Against It

The most direct counter-evidence concerns what the lumps are made of. A published chemical examination found material unlike ordinary gallstones and demonstrated that similar soft masses can form from the ingredients of the flush itself.

This matters because a real gallstone is not identified by color or appearance alone. A credible treatment study would first document actual stones, then measure whether they changed after the intervention.

There is also a safety distinction: a real stone lodged in a bile duct can cause obstruction, infection or pancreatitis. Making the gallbladder contract is not automatically a safe way to treat stones.

Common Viral Arguments

“I passed dozens of green stones right after the cleanse.”

The timing is real, but the same timing is consistent with formation from the ingredients inside the intestine.

“They float, so they are cholesterol stones.”

Floating is not a diagnostic test for gallstone origin. Composition must be measured.

“Ultrasound showed fewer stones afterward.”

That is more relevant evidence and should not be dismissed. It still requires controlled replication before efficacy can be assigned to the flush.

“Doctors refuse to recognize detox because it is natural.”

The key question is not whether the method is natural but whether the claimed material and outcome are objectively demonstrated.

The Reasoning Error

A correlation-causation error occurs when “lumps appeared after the flush” becomes “the gallbladder expelled them.” A category error treats any stone-like stool material as a biliary stone.

Cherry-picking can occur on both sides: promoters may ignore chemical analyses, while skeptics may ignore newer imaging-based case reports. A useful investigation keeps those evidence types separate.

What Would Change Our Conclusion?

A direct, reproducible result would require chemical analysis of recovered lumps and independently documented biliary composition/structure, ideally alongside before-and-after imaging that shows a specific previously identified gallstone leaving the gallbladder and a plausible passage path. Appropriate comparison material could include naturally passed stones and stool masses formed from the flush ingredients.

A robust randomized trial showing dissolution of imaged stones would update a different treatment-efficacy proposition, but would not, without specimen identification, show that the characteristic green stool lumps were the pre-existing stones.

Evidence Status

Status: Misleading
Evidence quality: Moderate

The familiar claim relies on the appearance of soft green lumps as proof of gallstone expulsion or liver “detoxification.” Chemical examination offers a different explanation for those lumps, and their appearance alone does not identify gallstones or toxins.

The chemical evidence directly addresses the visible-lump demonstration, but it comes from limited sampled material and cannot describe every individual case. Ultrasound reports and clinical studies of other regimens concern real stone changes, not the origin of the classic flush lumps. One experimental fatty-acid trial remained a protocol without posted efficacy results at the last review.

The appropriate distinction is between an object passed in stool, a stone confirmed by imaging, and a chemically identified toxin. They are three different kinds of evidence.

Sources

The foundational 2005 Lancet letter reports chemical assessment of material after a flush. Two 2026 case reports remain weak but relevant evidence about imaging of actual stones after multi-component regimens. The separate 2024 randomized UDCA-plus-omega-3 study concerns a different clinical treatment; its conflicting statistical caption is noted. The 2026 NCT06699030 protocol is labeled prospective research, not a completed trial. It plans six days of active formulation against placebo on days 1–3 then active on days 4–6; its day-3 primary imaging endpoint contradicts its sample-size subsection’s day-6 primary wording, and its intended n50 per arm is rounded below the computed ~52 after attrition adjustment. The original official ClinicalTrials.gov API was examined independently: NCT06699030 lists both day-3 and day-6 outcomes as primary, n100 planned, December 2025-verified Recruiting, last update December 31, 2025, and no results as of the October 9 check. The article calls day-3 primary and day-6 secondary, despite day-6 being ‘primary’ in its power subsection. History of registry outcome revisions was not accessible; the differing published documents do not prove a retrospective switch. The sources do not interchange stool chemistry, sonographic stone outcomes and undefined toxin excretion.

Corrections & Updates

October 9, 2026 — Official registry/source discrepancy: independently retrieved ClinicalTrials.gov NCT06699030 record lists BOTH day-3 and day-6 ultrasound clearance as primary endpoints, while the July 2026 peer-reviewed study protocol describes day-3 primary/day-6 secondary and contradicts itself in the sample-size subsection. Registry shows last December 2025-verified Recruiting status, December 2026 estimated completion, n100 planned, and no posted results as checked October 9; full registry version history could not be read. No claim of a proven retrospective change or completed efficacy results.

October 9, 2026 — Original protocol precision: corrected NCT06699030 six-day 50mL/day intervention, three-day placebo then three-day delayed-active control; distinguished day-3 placebo-controlled endpoint from day-6 duration comparison, and recorded conflicting primary-outcome statements and 47/0.9≈52 rounded down to 50/arm. No completed efficacy result or chemical verification of classic flush lumps.

October 8, 2026 — Evidence update: added a small 2024 randomized trial of ursodeoxycholic acid (UDCA) plus omega-3, a distinct 2026 protocol for very small stones, and their design and statistical limitations; verdict for classic flush claims unchanged.

Last Reviewed

October 9, 2026.